FOLH1 and prostate carcinoma: The LNCaP cell line, isolated from a subclavian lymph node metastasis of prostate cancer, maintains several key markers including prostate-specific antigen (PSA), prostate specific membrane antigen (PSMA) and the androgen receptor (AR) [47].